Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Mäki-Lohiluoma E"'
Autor:
Depuydt AS; Toxicology and Pharmacology, Campus Gasthuisberg, University of Leuven, Onderwijs en Navorsing 2, Herestraat 49, P.O. Box 922, 3000 Leuven, Belgium., Patel PA; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, P.O. Box 56 (Viikinkaari 5 E), University of Helsinki, FI-00014 Helsinki, Finland., Toplak Ž; Faculty of Pharmacy, University of Ljubljana, Aškerčeva cesta 7, 1000 Ljubljana, Slovenia., Bhat C; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, P.O. Box 56 (Viikinkaari 5 E), University of Helsinki, FI-00014 Helsinki, Finland., Voráčová M; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, P.O. Box 56 (Viikinkaari 5 E), University of Helsinki, FI-00014 Helsinki, Finland., Eteläinen I; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, P.O. Box 56 (Viikinkaari 5 E), University of Helsinki, FI-00014 Helsinki, Finland., Vitulano F; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, P.O. Box 56 (Viikinkaari 5 E), University of Helsinki, FI-00014 Helsinki, Finland., Bruun T; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, P.O. Box 56 (Viikinkaari 5 E), University of Helsinki, FI-00014 Helsinki, Finland., Lempinen A; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, P.O. Box 56 (Viikinkaari 5 E), University of Helsinki, FI-00014 Helsinki, Finland., Hribernik N; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, P.O. Box 56 (Viikinkaari 5 E), University of Helsinki, FI-00014 Helsinki, Finland., Mäki-Lohiluoma E; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, P.O. Box 56 (Viikinkaari 5 E), University of Helsinki, FI-00014 Helsinki, Finland., Hendrickx L; Toxicology and Pharmacology, Campus Gasthuisberg, University of Leuven, Onderwijs en Navorsing 2, Herestraat 49, P.O. Box 922, 3000 Leuven, Belgium., Pinheiro-Junior EL; Toxicology and Pharmacology, Campus Gasthuisberg, University of Leuven, Onderwijs en Navorsing 2, Herestraat 49, P.O. Box 922, 3000 Leuven, Belgium., Tomašič T; Faculty of Pharmacy, University of Ljubljana, Aškerčeva cesta 7, 1000 Ljubljana, Slovenia., Mašič LP; Faculty of Pharmacy, University of Ljubljana, Aškerčeva cesta 7, 1000 Ljubljana, Slovenia., Yli-Kauhaluoma J; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, P.O. Box 56 (Viikinkaari 5 E), University of Helsinki, FI-00014 Helsinki, Finland., Kiuru P; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, P.O. Box 56 (Viikinkaari 5 E), University of Helsinki, FI-00014 Helsinki, Finland., Tytgat J; Toxicology and Pharmacology, Campus Gasthuisberg, University of Leuven, Onderwijs en Navorsing 2, Herestraat 49, P.O. Box 922, 3000 Leuven, Belgium., Peigneur S; Toxicology and Pharmacology, Campus Gasthuisberg, University of Leuven, Onderwijs en Navorsing 2, Herestraat 49, P.O. Box 922, 3000 Leuven, Belgium.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2023 Feb 08; Vol. 24 (4). Date of Electronic Publication: 2023 Feb 08.
Autor:
Moreels, L., Bhat, C., Vorácová, M., Peigneur, S., Mäki-Lohiluoma, E., Zahed, F., Pardo, L.A., Yli-Kauhaluoma, J., Kiuru, P., Tytgat, J.
In the search for novel anticancer drugs, the potassium channel KV10.1 has emerged as an interesting cancer target. Here, we report a new group of KV10.1 inhibitors, namely the purpurealidin analogs. These alkaloids are produced by the Verongida spon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______232::576e3a5ba7c71414e609831c6d9893d6
http://www.vliz.be/imisdocs/publications/312174.pdf
http://www.vliz.be/imisdocs/publications/312174.pdf
Autor:
Mäki-Lohiluoma E; Orion Pharma, Orionintie 1, FI-02200 Espoo, Finland; University of Helsinki, Faculty of Pharmacy, Viikinkaari 5 E, 00014 University of Helsinki, Finland. Electronic address: eero.maki-lohiluoma@orion.fi., Säkkinen N; Top Data Science Ltd., Kuortaneenkatu 2, FI-00510 Helsinki, Finland., Palomäki M; Top Data Science Ltd., Kuortaneenkatu 2, FI-00510 Helsinki, Finland., Winberg O; Orion Pharma, Orionintie 1, FI-02200 Espoo, Finland., Ta HX; Top Data Science Ltd., Kuortaneenkatu 2, FI-00510 Helsinki, Finland., Heikkinen T; Top Data Science Ltd., Kuortaneenkatu 2, FI-00510 Helsinki, Finland., Kiljunen E; Orion Pharma, Orionintie 1, FI-02200 Espoo, Finland., Kauppinen A; Orion Pharma, Orionintie 1, FI-02200 Espoo, Finland.
Publikováno v:
International journal of pharmaceutics [Int J Pharm] 2021 Nov 20; Vol. 609, pp. 121146. Date of Electronic Publication: 2021 Sep 29.
Autor:
Staples JW; Department of Biomedical and Pharmaceuticals Sciences, University of Montana, Missoula, MT, United States., Stine JM; Department of Biomedical and Pharmaceuticals Sciences, University of Montana, Missoula, MT, United States., Mäki-Lohiluoma E; Department of Biomedical and Pharmaceuticals Sciences, University of Montana, Missoula, MT, United States., Steed E; Department of Biomedical and Pharmaceuticals Sciences, University of Montana, Missoula, MT, United States., George KM; Department of Biomedical and Pharmaceuticals Sciences, University of Montana, Missoula, MT, United States., Thompson CM; Department of Biomedical and Pharmaceuticals Sciences, University of Montana, Missoula, MT, United States., Woodahl EL; Department of Biomedical and Pharmaceuticals Sciences, University of Montana, Missoula, MT, United States. Electronic address: erica.woodahl@umontana.edu.
Publikováno v:
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association [Food Chem Toxicol] 2020 Dec; Vol. 146, pp. 111785. Date of Electronic Publication: 2020 Oct 01.
Autor:
Ervasti T; School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, 70210 Kuopio, Finland., Niinikoski H; School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, 70210 Kuopio, Finland., Mäki-Lohiluoma E; Orion Pharma Oyj, 02200 Espoo, Finland., Leppinen H; Orion Pharma Oyj, 02200 Espoo, Finland., Ketolainen J; School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, 70210 Kuopio, Finland., Korhonen O; School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, 70210 Kuopio, Finland., Lakio S; Orion Pharma Oyj, 02200 Espoo, Finland.
Publikováno v:
Pharmaceutics [Pharmaceutics] 2020 Mar 20; Vol. 12 (3). Date of Electronic Publication: 2020 Mar 20.
Publikováno v:
Eduvest: Journal Of Universal Studies. Jun2024, Vol. 4 Issue 6, p5422-5435. 14p.
Autor:
Bhat C; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, Viikinkaari 5 E (P.O. Box 56), University of Helsinki, FI-00014 Helsinki, Finland. chinmay.bht@gmail.com., Ilina P; Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, Viikinkaari 5 E (P.O. Box 56), University of Helsinki, FI-00014 Helsinki, Finland. polina.ilina@helsinki.fi., Tilli I; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, Viikinkaari 5 E (P.O. Box 56), University of Helsinki, FI-00014 Helsinki, Finland. irene.tilli@helsinki.fi., Voráčová M; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, Viikinkaari 5 E (P.O. Box 56), University of Helsinki, FI-00014 Helsinki, Finland. manuelavorac@gmail.com., Bruun T; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, Viikinkaari 5 E (P.O. Box 56), University of Helsinki, FI-00014 Helsinki, Finland. tanja.bruun@helsinki.fi., Barba V; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, Viikinkaari 5 E (P.O. Box 56), University of Helsinki, FI-00014 Helsinki, Finland. victoria.barba@ens-lyon.fr., Hribernik N; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, Viikinkaari 5 E (P.O. Box 56), University of Helsinki, FI-00014 Helsinki, Finland. nives.hribernik@gmail.com., Lillsunde KE; Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, Viikinkaari 5 E (P.O. Box 56), University of Helsinki, FI-00014 Helsinki, Finland. katja-emilia.lillsunde@helsinki.fi., Mäki-Lohiluoma E; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, Viikinkaari 5 E (P.O. Box 56), University of Helsinki, FI-00014 Helsinki, Finland. Eero.Maki-Lohiluoma@orion.fi., Rüffer T; Institute of Chemistry, Technische Universität Chemnitz, 09107 Chemnitz, Germany. tobias.rueffer@chemie.tu-chemnitz.de., Lang H; Institute of Chemistry, Technische Universität Chemnitz, 09107 Chemnitz, Germany. heinrich.lang@chemie.tu-chemnitz.de., Yli-Kauhaluoma J; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, Viikinkaari 5 E (P.O. Box 56), University of Helsinki, FI-00014 Helsinki, Finland. jari.yli-kauhaluoma@helsinki.fi., Kiuru P; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, Viikinkaari 5 E (P.O. Box 56), University of Helsinki, FI-00014 Helsinki, Finland. paula.kiuru@helsinki.fi., Tammela P; Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, Viikinkaari 5 E (P.O. Box 56), University of Helsinki, FI-00014 Helsinki, Finland. paivi.tammela@helsinki.fi.
Publikováno v:
Marine drugs [Mar Drugs] 2018 Dec 03; Vol. 16 (12). Date of Electronic Publication: 2018 Dec 03.
Autor:
Moreels L; Toxicology and Pharmacology, Department of Pharmaceutical and Pharmacological Sciences, University of Leuven (KU Leuven), Leuven, Belgium., Bhat C; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland., Voráčová M; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland., Peigneur S; Toxicology and Pharmacology, Department of Pharmaceutical and Pharmacological Sciences, University of Leuven (KU Leuven), Leuven, Belgium., Goovaerts H; Toxicology and Pharmacology, Department of Pharmaceutical and Pharmacological Sciences, University of Leuven (KU Leuven), Leuven, Belgium., Mäki-Lohiluoma E; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland., Zahed F; Oncophysiology Group, Max-Planck-Institute of Experimental Medicine, Göttingen, Germany., Pardo LA; Oncophysiology Group, Max-Planck-Institute of Experimental Medicine, Göttingen, Germany., Yli-Kauhaluoma J; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland., Kiuru P; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland., Tytgat J; Toxicology and Pharmacology, Department of Pharmaceutical and Pharmacological Sciences, University of Leuven (KU Leuven), Leuven, Belgium.
Publikováno v:
PloS one [PLoS One] 2017 Dec 08; Vol. 12 (12), pp. e0188811. Date of Electronic Publication: 2017 Dec 08 (Print Publication: 2017).
Autor:
Przywara, Mateusz1, Leś, Karolina Maria1 ichkl@prz.edu.pl, Piwódzka, Marta2, Chutkowski, Marcin1, Opaliński, Ireneusz1
Publikováno v:
Farmacja Polska. 2023, Vol. 79 Issue 10, p595-603. 9p.
Publikováno v:
Journal of Research in Pharmacy. 2023, Vol. 27 Issue 5, p1808-1820. 13p.